261
Views
2
CrossRef citations to date
0
Altmetric
Translational Research Paper

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression

, , , , &
Pages 1854-1867 | Received 08 Aug 2023, Accepted 31 Mar 2024, Published online: 09 Apr 2024

References

  • Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. doi: 10.5114/pg.2018.81072
  • Ye J, Lin M, Zhang C, et al. Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications. Biomed Rep. 2020;13(1):43–48. doi: 10.3892/br.2020.1303
  • Nakayama M, Oshima M. Mutant p53 in colon cancer. J Mol Cell Biol. 2019;11:267–276. doi: 10.1093/jmcb/mjy075
  • Zhu G, Pan C, Bei JX, et al. Mutant p53 in Cancer Progression and Targeted Therapies. Front Oncol. 2020;10:595187. doi: 10.3389/fonc.2020.595187
  • Tsvetkov P, Reuven N, Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ. 2010;17(1):103–108. doi: 10.1038/cdd.2009.67
  • Devine T, Dai MS. Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy. Curr Pharm Des. 2013;19(18):3248–3262. doi: 10.2174/1381612811319180009
  • Shi Y, Norberg E, Vakifahmetoglu-Norberg H. 2020. Mutant p53 as a Regulator and Target of Autophagy. Front Oncol. 10:607149. doi: 10.3389/fonc.2020.607149
  • Cordani M, Oppici E, Dando I, et al. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. Mol Oncol. 2016;10(7):1008–1029. doi: 10.1016/j.molonc.2016.04.001
  • Garufi A, Pucci D, D’Orazi V, et al. Degradation of mutant p53H175 protein by Zn(II) through autophagy. Cell Death Dis. 2014;5(5):e1271. doi: 10.1038/cddis.2014.217
  • Vakifahmetoglu-Norberg H, Kim M, Xia HG, et al. Chaperone-mediated autophagy degrades mutant p53. Genes Dev. 2013;27(15):1718–1730. doi: 10.1101/gad.220897.113
  • Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1. Autophagy. 2021;17(1):1–382. doi: 10.1080/15548627.2020.1797280
  • Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 2014;24(1):92–104. doi: 10.1038/cr.2013.153
  • Wu H, Chen S, Ammar AB, et al. Crosstalk between macroautophagy and chaperone-mediated autophagy: implications for the treatment of neurological diseases. Mol Neurobiol. 2015;52(3):1284–1296. doi: 10.1007/s12035-014-8933-0
  • D’Orazi G, Cirone M. Interconnected adaptive responses: a way out for cancer Cells to Avoid Cellular Demise. Cancers (Basel). 2022;14(11):14. doi: 10.3390/cancers14112780
  • Ren H, Zhai W, Lu X, et al. The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease. Front Aging Neurosci. 2021;13:691881. doi: 10.3389/fnagi.2021.691881
  • Martindale JJ, Fernandez R, Thuerauf D, et al. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res. 2006;98(9):1186–1193. doi: 10.1161/01.RES.0000220643.65941.8d
  • Yu Z, Sheng H, Liu S, et al. Activation of the ATF6 branch of the unfolded protein response in neurons improves stroke outcome. J Cereb Blood Flow Metab. 2017;37(3):1069–1079. doi: 10.1177/0271678X16650218
  • Xiao W, Cao RC, Yang WJ, et al. Roles and Clinical Significances of ATF6, EMC6, And APAF1 In Prognosis Of Pancreatic Cancer. Front Genet. 2021;12:730847. doi: 10.3389/fgene.2021.730847
  • Sicari D, Fantuz M, Bellazzo A, et al. Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6. Oncogene. 2019;38(34):6184–6195. doi: 10.1038/s41388-019-0878-3
  • Li W, Zhu J, Dou J, et al. Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagy. Nat Commun. 2017;8(1):1763. doi: 10.1038/s41467-017-01609-x
  • Granato M, Santarelli R, Lotti LV, et al. JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells. PLoS One. 2013;8(9):e75965. doi: 10.1371/journal.pone.0075965
  • Arena A, Romeo MA, Focaccetti C, et al. Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma. Br J Haematol. 2023;201(2). doi: 10.1111/bjh.18688
  • Benedetti R, Gilardini Montani MS, Romeo MA, et al. Role of UPR Sensor Activation in Cell Death–Survival Decision of Colon Cancer Cells Stressed by DPE Treatment. Biomedicines. 2021;9(9):1262. doi: 10.3390/biomedicines9091262
  • Benedetti R, Romeo MA, Arena A, et al. ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress. Cell Death Discov. 2022;8:295. doi: 10.1038/s41420-022-01085-3
  • Wang S, Hu B, Ding Z, et al. ATF6 safeguards organelle homeostasis and cellular aging in human mesenchymal stem cells. Cell Discov. 2018;4(1):2. doi: 10.1038/s41421-017-0003-0
  • Dang TT, Kim MJ, Lee YY, et al. Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress. Autophagy. 2023;19(7):1–32. doi: 10.1080/15548627.2023.2173900
  • Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433. doi: 10.1126/science.1204592
  • Geisslinger F, Muller M, Vollmar AM, et al. 2020. Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance-A Mini Review. Front Oncol. 10:1156. doi: 10.3389/fonc.2020.01156
  • Masuelli L, Granato M, Benvenuto M, et al. Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice. Oncoimmunology. 2017;6(11):e1356151. doi: 10.1080/2162402X.2017.1356151
  • Granato M, Rizzello C, Romeo MA, et al. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt’s lymphoma. Int J Biochem Cell Biol. 2016;79:393–400. doi: 10.1016/j.biocel.2016.09.006
  • Park C, Suh Y, Cuervo AM. Regulated degradation of Chk1 by chaperone-mediated autophagy in response to DNA damage. Nat Commun. 2015;6(1):6823. doi: 10.1038/ncomms7823
  • Barberi-Heyob M, Vedrine PO, Merlin JL, et al. Wild-type p53 gene transfer into mutated p53 HT29 cells improves sensitivity to photodynamic therapy via induction of apoptosis. Int J Oncol. 2004;24:951–958. doi: 10.3892/ijo.24.4.951
  • Rochette PJ, Bastien N, Lavoie J, et al. SW480, a p53 double-mutant cell line retains proficiency for some p53 functions. J Mol Biol. 2005;352(1):44–57. doi: 10.1016/j.jmb.2005.06.033
  • Ganley IG, Wong PM, Gammoh N, et al. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell. 2011;42(6):731–743. doi: 10.1016/j.molcel.2011.04.024
  • Halasi M, Pandit B, Gartel AL. Proteasome inhibitors suppress the protein expression of mutant p53. Cell Cycle. 2014;13(20):3202–3206. doi: 10.4161/15384101.2014.950132
  • Losmanova T, Janser FA, Humbert M, et al. Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung. Oxid Med Cell Longev. 2020;2020:8506572. doi: 10.1155/2020/8506572
  • Granato M, Lacconi V, Peddis M, et al. HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis. 2013;4(7):e730. doi: 10.1038/cddis.2013.263
  • Franco-Juarez B, Coronel-Cruz C, Hernandez-Ochoa B, et al. TFEB; Beyond Its Role as an Autophagy and Lysosomes Regulator. Cells. 2022;11(19):11. doi: 10.3390/cells11193153
  • Huang J, Wang X, Zhu Y, et al. Exercise activates lysosomal function in the brain through AMPK-SIRT1-TFEB pathway. CNS Neurosci Ther. 2019;25(6):796–807. doi: 10.1111/cns.13114
  • Napolitano G, Esposito A, Choi H, et al. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat Commun. 2018;9(1):3312. doi: 10.1038/s41467-018-05862-6
  • Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci U S A. 2008;105(30):10519–10524. doi: 10.1073/pnas.0800939105
  • Ogata M, Hino S, Saito A, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 2006;26(24):9220–9231. doi: 10.1128/MCB.01453-06
  • Puertollano R. 2014. mTOR and lysosome regulation. F1000Prime Rep. 6:52. doi: 10.12703/P6-52
  • Dando I, Cordani M, Donadelli M. Mutant p53 and mTOR/PKM2 regulation in cancer cells. IUBMB Life. 2016;68(9):722–726. doi: 10.1002/iub.1534
  • Zhou J, Tan SH, Nicolas V, et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Cell Res. 2013;23(4):508–523. doi: 10.1038/cr.2013.11
  • Huang X, Shi D, Zou X, et al. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Theranostics. 2023;13(1):339–354. doi: 10.7150/thno.78492
  • Chen X, Zhang T, Su W, et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022;13(11):974. doi: 10.1038/s41419-022-05408-1
  • D’Orazi G, Cirone M. Mutant p53 and cellular stress pathways: a criminal alliance that promotes cancer progression. Cancers (Basel). 2019;11(5):11. doi: 10.3390/cancers11050614
  • D’Orazi G, Cordani M, Cirone M. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies. Cell Mol Life Sci. 2021;78(5):1853–1860. doi: 10.1007/s00018-020-03677-7
  • Collavin L, Lunardi A, Del Sal G. p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ. 2010;17(6):901–911. doi: 10.1038/cdd.2010.35
  • Gilardini Montani MS, Cecere N, Granato M, et al. Mutant p53, stabilized by its interplay with HSP90, activates a Positive Feed-Back Loop Between NRF2 and p62 that induces chemo-resistance to Apigenin in pancreatic cancer Cells. Cancers (Basel). 2019;11(5):11. doi: 10.3390/cancers11050703
  • Rashid HO, Yadav RK, Kim HR, et al. ER stress: autophagy induction, inhibition and selection. Autophagy. 2015;11(11):1956–1977. doi: 10.1080/15548627.2015.1091141
  • Cecchinelli B, Lavra L, Rinaldo C, et al. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol. 2006;26(12):4746–4757. doi: 10.1128/MCB.00959-05
  • Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145. doi: 10.1074/jbc.M702824200
  • Wang Y, Shen J, Arenzana N, et al. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem. 2000;275(35):27013–27020. doi: 10.1016/S0021-9258(19)61473-0
  • Gilardini Montani MS, Benedetti R, Piconese S, et al. PGE2 released by pancreatic cancer cells undergoing ER stress transfers the stress to DCs impairing their immune function. Mol Cancer Ther. 2021;20(5):934–945. doi: 10.1158/1535-7163.MCT-20-0699

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.